We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
ProShares UltraPro Short QQQ
SQQQ
$1.73B
| $18.9K | ﹤0.01% |
40
-40
| -50% | -$25.9K |
|
|
LTHM
1127
DELISTED
Livent Corporation
LTHM
| $18.8K | ﹤0.01% |
687
+160
| +30% | +$3.84K |
|
|
HTBK
1128
DELISTED
Heritage Commerce
HTBK
| $18.8K | ﹤0.01% |
2,274
+2,134
| +1,524% | +$16.9K |
|
1129
Veeva Systems
VEEV
$38B
| $18.8K | ﹤0.01% |
95
-31
| -25% | -$5.65K |
|
1130
Antero Resources
AR
$11.1B
| $18.8K | ﹤0.01% |
815
-1
| -0.1% | -$22 |
|
1131
Insulet
PODD
$9.88B
| $18.7K | ﹤0.01% |
65
-49
| -43% | -$14.9K |
|
1132
Donaldson
DCI
$11.3B
| $18.7K | ﹤0.01% |
299
| – | – |
|
1133
Weibo
WB
$1.95B
| $18.5K | ﹤0.01% |
1,412
-138
| -9% | -$2.19K |
|
1134
First Financial Corp
THFF
$966M
| $18.5K | ﹤0.01% |
570
+522
| +1,088% | +$17.8K |
|
1135
iShares Core S&P US Value ETF
IUSV
$27.7B
| $18.5K | ﹤0.01% |
236
| – | – |
|
1136
Stanley Black & Decker
SWK
$15.4B
| $18.5K | ﹤0.01% |
197
-182
| -48% | -$15.1K |
|
1137
BOK Financial
BOKF
$8.68B
| $18.4K | ﹤0.01% |
228
-130
| -36% | -$10.7K |
|
|
MDC
1138
DELISTED
M.D.C. Holdings, Inc.
MDC
| $18.4K | ﹤0.01% |
393
+7
| +2% | +$291 |
|
1139
Annaly Capital Management
NLY
$17.1B
| $18.4K | ﹤0.01% |
918
-59
| -6% | -$1.15K |
|
1140
Murphy Oil
MUR
$5B
| $18.3K | ﹤0.01% |
479
+59
| +14% | +$2.18K |
|
1141
Brink's
BCO
$4.53B
| $18.3K | ﹤0.01% |
270
-7
| -3% | -$468 |
|
1142
Iridium Communications
IRDM
$5.25B
| $18.3K | ﹤0.01% |
294
+21
| +8% | +$1.3K |
|
1143
Terreno Realty
TRNO
$7.42B
| $18.2K | ﹤0.01% |
303
| – | – |
|
1144
Cogent Communications
CCOI
$506M
| $18.1K | ﹤0.01% |
269
+4
| +2% | +$261 |
|
1145
Vanguard FTSE All-World ex-US ETF
VEU
$70B
| $18K | ﹤0.01% |
331
| – | – |
|
1146
Axalta
AXTA
$8.04B
| $17.9K | ﹤0.01% |
547
+10
| +2% | +$310 |
|
1147
Macerich
MAC
$6.86B
| $17.9K | ﹤0.01% |
1,585
| – | – |
|
1148
VF Corp
VFC
$5.84B
| $17.8K | ﹤0.01% |
935
-995
| -52% | -$20.4K |
|
|
UNIT
1149
Uniti Group
UNIT
$2.27B
| $17.8K | ﹤0.01% |
3,862
+2,646
| +218% | +$9.95K |
|
1150
Telephone and Data Systems
TDS
$3.72B
| $17.8K | ﹤0.01% |
2,164
+406
| +23% | +$3.44K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.